As of June 30, 2026, Basma Adeem Medical Co. carries a market capitalization of 125.00M, placing it among publicly traded companies globally. Its enterprise value stands at 106.35M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 125.00M |
| Enterprise Value | 106.35M |
As of June 30, 2026, Basma Adeem Medical Co. has 20.00M shares outstanding.
| Shares Outstanding | 20.00M |
These figures are as of June 30, 2026.
| PB Ratio | 2.46 |
| P/TBV Ratio | 2.46 |
As of June 30, 2026, Basma Adeem Medical Co. maintains a current ratio of 6.47, meaning it holds 6.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.47 |
| Quick Ratio | 5.75 |
| Debt / Equity | 40.48 |
As of the close on November 16, 2026, Basma Adeem Medical Co.'s stock has gained approximately 22.71% over the past 52 weeks. The 50-day moving average sits at 6.25, while the 200-day moving average is 5.88.
| 52-Week Price Change | 22.71% |
| 50-Day Moving Average | 6.25 |
| 200-Day Moving Average | 5.88 |
As of June 30, 2026, Basma Adeem Medical Co. holds 39.24M in cash and equivalents against 20.59M in total debt, resulting in a net debt position of -19.02M. Total book value stands at 50.86M, with working capital of 37.30M providing operational flexibility.
| Cash & Cash Equivalents | 39.24M |
| Total Debt | 20.59M |
| Net Debt | -19.02M |
| Equity (Book Value) | 50.86M |
| Book Value Per Share | 2.54 |
| Working Capital | 37.30M |
Already premium?